作者
Lovorka Grgurevic, Igor Erjavec, Ivica Grgurevic, Ivo Dumic-Cule, Jelena Brkljacic, Donatella Verbanac, Mario Matijasic, Hana Cipcic Paljetak, Rudjer Novak, Mihovil Plecko, Jadranka Bubic-Spoljar, Dunja Rogic, Vera Kufner, Martina Pauk, Tatjana Bordukalo-Niksic, Slobodan Vukicevic
发表日期
2017/11/2
期刊
Growth Factors
卷号
35
期号
6
页码范围
201-215
出版商
Taylor & Francis
简介
Liver fibrosis is a progressive pathological process resulting in an accumulation of excess extracellular matrix proteins. We discovered that bone morphogenetic protein 1-3 (BMP1-3), an isoform of the metalloproteinase Bmp1 gene, circulates in the plasma of healthy volunteers and its neutralization decreases the progression of chronic kidney disease in 5/6 nephrectomized rats. Here, we investigated the potential role of BMP1-3 in a chronic liver disease. Rats with carbon tetrachloride (CCl4)-induced liver fibrosis were treated with monoclonal anti-BMP1-3 antibodies. Treatment with anti-BMP1-3 antibodies dose-dependently lowered the amount of collagen type I, downregulated the expression of Tgfb1, Itgb6, Col1a1, and Acta2 and upregulated the expression of Ctgf, Itgb1, and Dcn. Mehanistically, BMP1-3 inhibition decreased the plasma levels of transforming growth factor beta 1(TGFβ1) by prevention of its …
引用总数
201920202021202220232024273632
学术搜索中的文章